About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Endocrine-Disrupting Chemical Raises Risk of Precancerous Prostate Lesions

by Bidita Debnath on June 25, 2014 at 9:51 PM
Font : A-A+

 Endocrine-Disrupting Chemical Raises Risk of Precancerous Prostate Lesions

For the first time, a new study has found that the endocrine-disrupting chemical bisphenol A (BPA) reprograms the developing prostate, making the gland more susceptible to precancerous lesions and other diseases later in a man's life.

The results will be reported Sunday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago.

Advertisement

"By using two novel models of human prostate development involving embryonic stem cells, this study is the first to show that low doses of BPA can actually reprogram human fetal prostate tissue in a manner that raises the risk of prostate diseases as men age," said the study's presenting author, Esther Calderon-Gierszal, a PhD student at the University of Illinois at Chicago, Chicago, IL.

BPA is a chemical used to manufacture certain plastics and is often found in water bottles, food storage containers and other consumer products. BPA disrupts the normal functioning of the body's hormones by mimicking the hormone estrogen.
Advertisement

Past studies of adult prostate stem cells and animal models found that BPA exposure increased the risk of developing prostate cancer, so researchers at the University of Chicago at Illinois set out to examine the effect in human embryonic prostate cells. The study was the first to generate a human fetal prostate model grown in a dish in a laboratory. In addition, researchers developed a human-like model in a mouse to study the effects of BPA on the developing prostate.

When the human fetal prostate model grown in the laboratory was exposure to low doses of BPA, investigators reported that exposure altered fetal prostate formation and increased the number of stem cells in the adult prostate, which could lead to aberrant growth and disease with aging. This type of cell activity eventually could lead to the development of prostate cancer.

To observe the effects of BPA in prostate tissue grown in a host mouse, researchers combined human embryonic stem cells and rat cells called mesenchyme. The researchers then grafted the combined tissue on to the kidneys of mice where it developed into human-like prostate tissue. The experiment modeled human BPA exposure feeding the mice low-dose BPA which led to the development of lesions in the human prostate tissue, including a precancerous lesion known as prostate intraepithelial neoplasia, or PIN.

"Using human embryonic stem cells to generate prostate tissues, we were able to document the direct effect low-dose BPA exposure had in driving prostate pathology and disease," Calderon-Gierszal said.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Health Benefits of Giloy
Breast Cancer Awareness Month 2021 - It's time to RISE
First-Ever Successful Pig-To-Human Kidney Transplantation
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Prostate Cancer Trans-Urethral Resection of the Prostate Prostate Cancer: Treatment Options Prostate Specific Antigen [PSA] Medical Management of Prostate Cancer 

Recommended Reading
Nonsurgical Treatment for Prostate Enlargement Underway
A nonsurgical treatment for prostate enlargement via pulsed electromagnetic field therapy (PEMF) is ...
Effectiveness of Focal Treatment for Prostate Cancer Probed
Previous research has shown that focal therapy for prostate cancer can prolong life, result in less ...
ProMark Accurately Predicts Aggressive Prostate Cancer, Pathology Outcomes
Metamark has for the first time, presented results the clinical validation study that showed ......
Most Prostate Cancer Specialists Don't Recommend Active Surveillance for Their Patients
Specialists who treat prostate cancer agree that active surveillance is an effective option — yet .....
Medical Management of Prostate Cancer
Prostate cancer is the second most common cancer in men after skin cancer and it is the sixth leadin...
Prostate Cancer
This cancer affects men over the age of 50 years and screening with rectal examination and PSA can h...
Prostate Cancer: Treatment Options
Treatment options of prostate cancer includes waiting, surgery, radiation, hormone therapy, chemothe...
Prostate Specific Antigen [PSA]
PSA blood test is specific to prostate gland but not necessarily a cancer specific test but is commo...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use